ESR1 and breast carcinoma: In a subsequent study, the same group developed a new sequencing approach called Nuc-Seq, which is a high-coverage, whole-exome single cell sequencing method, which was applied in two breast cancer patients, one with an ER+ invasive ductal carcinoma and the other with TNBC, to investigate the mutational landscape of their tumors [50].